UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000026869
Receipt No. R000030832
Scientific Title Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patients
Date of disclosure of the study information 2017/04/05
Last modified on 2017/04/05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patients
Acronym Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patients
Scientific Title Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patients
Scientific Title:Acronym Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patients
Region
Japan

Condition
Condition Non-small cell lung cancer
Classification by specialty
Chest surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to evaluate Galectin-3 expression as a prognostic factor in patients with surgically resected non-small cell lung cancer.
Basic objectives2 Others
Basic objectives -Others We examine the correlation between Galectin-3 expression in non-small cell lung cancer and clinicopahtological features.
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Recurrence-free survival (RFS)
Key secondary outcomes 1) Overall survival (OS)
2) To evaluate the correlation between Galectin-3 expression in non-small cell lung cancer tissues and clinicopathological features
3) To investigate the correlation between Galectin-3 expression in tissue and serum from non-small cell lung cancer patients

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Non-small cell lung cancer patients who underwent surgical resection in Shiga University of Medical Science Hospital between January 2007 and December 2015.
Key exclusion criteria Not applicable
Target sample size 250

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yoko Kataoka
Organization Shiga University of Medical Science
Division name Department of Surgery
Zip code
Address Seta-Tsukinowa, Otsu, Shiga
TEL 077-548-2244
Email hqsurg2@belle.shiga-med.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Yoko Kataoka
Organization Shiga University of Medical Science
Division name Department of Surgery
Zip code
Address Seta-Tsukinowa, Otsu, Shiga
TEL 077-548-2244
Homepage URL
Email hqsurg2@belle.shiga-med.ac.jp

Sponsor
Institute Shiga University of Medical Science
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 04 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2017 Year 04 Month 01 Day
Date of IRB
Anticipated trial start date
2017 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information To evaluate Galectin-3 expression as a prognostic factor in patients with surgically resected non-small cell lung cancer.

Management information
Registered date
2017 Year 04 Month 05 Day
Last modified on
2017 Year 04 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030832

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.